Prevention of gastric cancer

JAMA - Journal of the American Medical Association

Volumn 312, Issue 12, 2014, Pages 1197-1198

  Herrero, Rolando ^a   Parsonnet, Julie ^b   Greenberg, Edwin Robert ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

ANTIBIOTIC RESISTANCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CHINA; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DYSPEPSIA; ENDOSCOPIC MUCOSAL RESECTION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HELICOBACTER INFECTION; HUMAN; INFECTION PREVENTION; INTESTINE FLORA; META ANALYSIS (TOPIC); PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; STOMACH CANCER; UNITED STATES; ARTICLE; HEALTH CARE POLICY; MICROBIOLOGY; STOMACH TUMOR;

HEALTH POLICY; HELICOBACTER INFECTIONS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STOMACH NEOPLASMS; UNITED STATES;

EID: 84907546676     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.10498     Document Type: Short Survey

References (10)

1. International Agency for Research on Cancer. Stomach cancer. Estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/old/FactSheets/cancers/stomach-new.asp. Accessed April 25, 2014.
2. National Cancer Institute at the National Institutes of Health. A snapshot of stomach cancer. http://www.cancer.gov/researchandfunding/snapshots/stomach. Accessed July 22, 2014.
3. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, BrownML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128.
4. Plummer M, Franceschi S, Vignat V, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori [published online May 29, 2014]. Int J Cancer. doi:10.1002/ijc.28999.
5. Ma JL, Zhang L, Brown LM, et al. Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst. 2012;104(6):488-492.
6. Ford AC, Forman D, Hunt RH, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ. 2014;348:g3174.
7. Lane JA, Murray LJ, Noble S, et al. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial. BMJ. 2006;332(7535):199-204.
8. Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ. 2013;347:f4587.
9. Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27(6):933-947.
10. International Agency for Research on Cancer. IARC Working Group Reports. Helicobacter pylori: eradication as a strategy for preventing gastric cancer. http://www.iarc.fr/en/publications/pdfs-online/wrk/wrk8/. Accessed August 28, 2014.